Xofluza
NDC 50090-4104
Product Information
Xofluza is a NDA-approved product labeled by A-s Medication Solutions. Baloxavir marboxil is an antiviral medication used to treat the flu (influenza) if your symptoms started less than 48 hours ago. It is supplied as a yellow product. This product entry covers the primary NDC 50090-4104 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
BXM40
Code Structure Chart
Product Details
What is NDC 50090-4104?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BALOXAVIR MARBOXIL (UNII: 505CXM6OHG)
- BALOXAVIR MARBOXIL (UNII: 505CXM6OHG) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- POVIDONE K25 (UNII: K0KQV10C35)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2100008 - baloxavir marboxil 40 MG Oral Tablet
- RxCUI: 2100010 - Xofluza 40 MG Oral Tablet
- RxCUI: 2100010 - baloxavir marboxil 40 MG Oral Tablet [Xofluza]
- RxCUI: 2100026 - {2 (baloxavir marboxil 40 MG Oral Tablet) } Pack
- RxCUI: 2100026 - baloxavir marboxil 80 MG Dose Pack (2 x 40 MG Tablets)
* Please review the full disclaimer at the bottom of this page.
Patient Education
Baloxavir Marboxil
Baloxavir marboxil is used to treat some types of influenza infection ('flu') in adults and children 5 years and older who have had symptoms of the flu for no longer than 2 days and who are otherwise healthy or are at high risk for developing influenza-related complications. Baloxavir marboxil is also used to treat some types of flu in adults and children 12 years and older who have had symptoms of the flu for no longer than 2 days and who are at high risk for developing influenza-related complications. It is also used to prevent some types of flu in adults and children 5 years and older when they have spent time with someone who has the flu. Baloxavir marboxil is in a class of medications called polymerase acidic endonuclease inhibitors. It works by stopping the spread of the flu virus in the body. Baloxavir marboxil helps to shorten the time that flu symptoms such as a stuffy or runny nose, sore throat, cough, muscle or joint aches, tiredness, headache, fever, and chills last. Baloxavir marboxil will not prevent bacterial infections, which may occur as a complication of the flu.
[Learn More]
* Please review the full disclaimer at the bottom of this page.